Triple
T22693617
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Teglutik |
E561110
|
entity |
| Predicate | bioequivalence |
P149329
|
FINISHED |
| Object | bioequivalent to riluzole tablets in systemic exposure |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: bioequivalent to riluzole tablets in systemic exposure | Statement: [Teglutik, bioequivalence, bioequivalent to riluzole tablets in systemic exposure]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: bioequivalence Context triple: [Teglutik, bioequivalence, bioequivalent to riluzole tablets in systemic exposure]
-
A.
hasBioavailability
Indicates that a substance has a specified degree or measure of bioavailability, i.e., the proportion that enters circulation and can have an active effect.
-
B.
hasBiosimilar
Indicates that one biological product is a biosimilar counterpart to another reference biological product.
-
C.
notableBiosimilarArea
Indicates that an entity is significantly involved in, or recognized for, work related to a particular biosimilar product or therapeutic area.
-
D.
isProdrug
Indicates that one substance is a prodrug of another, meaning it is administered in an inactive or less active form and is metabolically converted into the active drug in the body.
-
E.
isProdrugOf
Indicates that one substance is a precursor form that is metabolized in the body to produce the active form of another substance.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789c6ae481908975b7d27e7624ac |
completed | April 29, 2026, 3:18 a.m. |
| PD | Predicate disambiguation | batch_69ee62b2259c819091ed1387a748b9f3 |
completed | April 26, 2026, 7:08 p.m. |
| PDg | Predicate description generation | batch_69ee8843d3308190b6e22bb98ae5c3d8 |
completed | April 26, 2026, 9:48 p.m. |
Created at: April 17, 2026, 3:13 p.m.